Health Care and Education Reconciliation Act of 2010

Oscar Health Announces Results for Third Quarter 2023 and Raises Full Year 2023 Adjusted EBITDA Outlook; New +Oscar Agreement

Retrieved on: 
Tuesday, November 7, 2023

Actual results may differ materially depending on a number of factors.

Key Points: 
  • Actual results may differ materially depending on a number of factors.
  • Investors are urged to read the Cautionary Note Regarding Forward-Looking Statements included in this release.
  • Oscar will host a conference call to discuss the financial results today, November 7, 2023, at 8:00 a.m. (ET).
  • New factors emerge from time to time, and it is not possible for us to predict which will arise.

Oscar Health Announces Strong Financial Results for Second Quarter 2023

Retrieved on: 
Tuesday, August 8, 2023

Oscar will host a conference call to discuss the financial results today, August 8, 2023, at 5:00 p.m. (ET).

Key Points: 
  • Oscar will host a conference call to discuss the financial results today, August 8, 2023, at 5:00 p.m. (ET).
  • A live audio webcast and a supplemental presentation will be available via the Investor Relations page of Oscar’s website at ir.hioscar.com.
  • This release presents Adjusted EBITDA, a non-GAAP financial metric, which is provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America (“GAAP”).
  • A reconciliation of the non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release.

Oscar Health Announces Results for First Quarter 2023 With Meaningful YoY Improvements Across all KPIs

Retrieved on: 
Tuesday, May 9, 2023

Oscar will host a conference call to discuss the financial results today, May 9, 2023, at 5:00 p.m. (ET).

Key Points: 
  • Oscar will host a conference call to discuss the financial results today, May 9, 2023, at 5:00 p.m. (ET).
  • A live audio webcast and a supplemental presentation will be available via the Investor Relations page of Oscar’s website at ir.hioscar.com.
  • This release presents Adjusted EBITDA, a non-GAAP financial metric, which is provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America (“GAAP”).
  • New factors emerge from time to time, and it is not possible for us to predict which will arise.

Oscar Health Announces Results for Fourth Quarter and Full Year 2022

Retrieved on: 
Thursday, February 9, 2023

Oscar has not provided a quantitative reconciliation of forecasted Adjusted EBITDA to forecasted GAAP net loss within this press release because Oscar is unable, without making unreasonable efforts, to calculate certain reconciling items with confidence.

Key Points: 
  • Oscar has not provided a quantitative reconciliation of forecasted Adjusted EBITDA to forecasted GAAP net loss within this press release because Oscar is unable, without making unreasonable efforts, to calculate certain reconciling items with confidence.
  • As such, any associated estimate and its impact on GAAP net loss could vary materially.
  • Oscar will host a conference call to discuss the financial results today, February 9, 2023, at 5:00 p.m. (ET).
  • New factors emerge from time to time, and it is not possible for us to predict which will arise.

Innovation, Communities, and Health Care Thought Leaders featured at the 34th Quest for Excellence® Conference

Retrieved on: 
Wednesday, January 25, 2023

WASHINGTON, D.C., Jan. 25, 2023 /PRNewswire/ -- Baldrige Foundation President and CEO Al Faber announced that registration has opened for the 34th Quest for Excellence® Conference, Sunday, April 2–Wednesday, April 5, 2023, at the Gaylord National Harbor Resort and Convention Center. You may register today with this link.

Key Points: 
  • This is the first expansion of the awards since Health Care and Education were added in 1998 and the Nonprofit category was added in 2005.
  • This year, Quest will shine a light on best practices in innovation and healthy, thriving communities during its Monday and Wednesday plenary sessions.
  • Quest will also feature presentations by Baldrige Award-winning health care organizations, including Adventist Health White Memorial , GBMC Healthcare, Inc. , Mary Greeley Medical Center , Memorial Hermann Sugar Land Hospital , and Southcentral Foundation .
  • Learn how these organizations have achieved high performance in the face of today's challenges in the health care sector.

Oscar Health, Inc. to Limit Additional Growth in Florida in Light of Strong Open Enrollment

Retrieved on: 
Monday, December 12, 2022

They can renew their plan for 2023 throughout the remainder of Open Enrollment through the exchange or their broker.

Key Points: 
  • They can renew their plan for 2023 throughout the remainder of Open Enrollment through the exchange or their broker.
  • Any new Oscar member in Florida that has enrolled in Oscar for 2023 prior to December 13 at 12:00 a.m. EST will not be impacted.
  • Oscar remains steadfast in the Florida market and intends to continue to provide coverage throughout 2023 and beyond.
  • Prior to Open Enrollment, the company requested that regulators limit its membership growth in Florida so that total membership across all markets would be within its previously announced target range of 1M members, +/-10%.

CENTENE CORPORATION ANNOUNCES 2023 GUIDANCE

Retrieved on: 
Friday, December 16, 2022

The twelve months ended December 31, 2023 also includes a one-time income tax benefit of $0.12 resulting from the vesting of long-term stock awards distributable to the estate of Mr. Neidorff during Q1 2023.

Key Points: 
  • The twelve months ended December 31, 2023 also includes a one-time income tax benefit of $0.12 resulting from the vesting of long-term stock awards distributable to the estate of Mr. Neidorff during Q1 2023.
  • Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives.
  • Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors.
  • Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, https://investors.centene.com/ .

CENTENE APPOINTS MONTE FORD TO BOARD OF DIRECTORS

Retrieved on: 
Wednesday, November 16, 2022

ST. LOUIS, Nov. 16, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that it has appointed Monte Ford to the Centene Board of Directors, effective November 12th.

Key Points: 
  • ST. LOUIS, Nov. 16, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that it has appointed Monte Ford to the Centene Board of Directors, effective November 12th.
  • Mr. Ford is a leading technologist with more than 20 years of board experience serving Fortune 500 companies across a wide spectrum of industries.
  • "Monte's extensive experience in the Fortune 500 technology sector will serve Centene well as we continue to use data to drive innovation and transform healthcare for our members," said James Dallas,Chairman of the Centene Board of Directors.
  • "I look forward to working with Centene, a company with which I share a vision of transforming healthcare through innovative technology and programs," said Ford.

Elevance Health to Acquire BioPlus

Retrieved on: 
Wednesday, November 9, 2022

Elevance Health (NYSE: ELV) today announced that it has entered into an agreement with CarepathRx, a portfolio company of Nautic Partners, to acquire BioPlus, a comprehensive specialty pharmacy.

Key Points: 
  • Elevance Health (NYSE: ELV) today announced that it has entered into an agreement with CarepathRx, a portfolio company of Nautic Partners, to acquire BioPlus, a comprehensive specialty pharmacy.
  • This acquisition will help Elevance Health meet the specialty drug needs of its clients and customers with a whole-health approach, supported by integrated programs across Elevance Health and Carelon, Elevance Healths healthcare services brand.
  • In making BioPlus part of the Elevance Health family, we are committed to leveraging our resources to scale and broaden the reach of BioPlus best-in-class specialty pharmacy capabilities, delivering greater affordability and access to critical medications.
  • Elevance Health is a lifetime, trusted health partner fueled by its purpose to improve the health of humanity.

Elevance Health’s Affiliated 2023 Medicare Advantage Health Plans Earn High Quality Scores from CMS

Retrieved on: 
Friday, October 7, 2022

Many of Elevance Healths affiliated Medicare Advantage plans retained strong ratings of 4, 4.5 and 5 Stars, and 64 percent of consumers in Elevance Health affiliated plans will be enrolled in a Medicare Advantage plan rated 4 Stars or better next year.

Key Points: 
  • Many of Elevance Healths affiliated Medicare Advantage plans retained strong ratings of 4, 4.5 and 5 Stars, and 64 percent of consumers in Elevance Health affiliated plans will be enrolled in a Medicare Advantage plan rated 4 Stars or better next year.
  • Two Elevance Health affiliated Medicare Advantage plans will be rated 5 Stars the highest score that can be achieved through CMSs Star Ratings program.
  • Elevance Health's affiliated health plans are Medicare Advantage Organizations and Prescription Drug Plans with Medicare contracts issued by CMS.
  • Elevance Health's affiliated health plans are HMO, HMO DSNP, LPPO, RPPO plans with Medicare contracts and contracts with the appropriate state Medicaid programs.